Author

Géraldine Gentric

InsermORCID 0000-0002-7558-8705Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Catherine BrenneriD· 1 shared Christine PéchouxiD· 1 shared Clara NahmiasiD· 1 shared Cynthia Seiler· 1 shared Damarys LoewiD· 1 shared Diego ChianeseiD· 1 shared Evanthia PangouiD· 1 shared Fatima Mechta‐GrigoriouiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Catherine BrennerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Connecting mitochondrial metabolism and mitotic fidelity to control vulnerability of high grade serous ovarian cancer patients to taxane-based chemotherapy

Hadia Moindjie, Morgane Morin, Evanthia Pangou, Diego Chianese, Cynthia Seiler, Sylvie Rodrigues-Ferreira, Maria M. Haykal, Christine Péchoux, Florent Dingli, Damarys Loew, Yann Kieffer, Géraldine Gentric, Patricia Pautier, Philippe Dessen, Rafael José Argüello, , Clara Nahmias

This paper identifies syntabulin as a determinant of chemosensitivity in high-grade serous ovarian cancer by linking mitochondrial metabolism and mitotic fidelity.

bioRxiv · Jan 8, 2026 · PreprintCancer Biology